
- Tissu
- Peripheral blood
- Maladie
- Precursor T-cell acute lymphoblastic leukemia
- Site métastatique
- Peripheral blood (systemic T-ALL)
- Synonymes
- HPB/ALL, HPBALL, FCCH1018
Documents
HPB-ALL
Cell line · Référence du produit 302895
HPB-ALL est une lignée cellulaire issue d'une leucémie lymphoblastique aiguë à cellules T précurseurs humaines (LLA-T) établie à partir du sang périphérique d'un garçon japonais de 14 ans...
Personnalisation / Recommandations
- HPB-ALLCell line€430.00
Recommandé (lot le plus récent)
01Informations générales
- Description
HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.
HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.
- Tissu
- Peripheral blood
- Maladie
- Precursor T-cell acute lymphoblastic leukemia
- Site métastatique
- Peripheral blood (systemic T-ALL)
- Applications
- T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
- Synonymes
- HPB/ALL
- HPBALL
- FCCH1018
02Classification
- Organisme
- Humain
- Sexe
- Homme
- Propriétés de croissance
- Suspension
- Niveau de biosécurité
- 1
03Caractéristiques
- Morphologie
- Lymphoblast-like
- Type de cellule
- T-cell
- Temps de doublement
- ~50 hours
04Identifiants
- Référence
- HPB-ALL (Cytion catalog number 302895)
- Numéro d'identification fiscale NCBI
- 9606
- Cellosaurus
- CVCL_1820
05Expression et sensibilité
- Profil mutationnel
- Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified
06Manipulation et culture
- Milieu de culture
- RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
- Compléments alimentaires
- Supplement the medium with 10% FBS
- Réactif de dissociation
- dilution
- Repiquage
- Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
- Rapport de fractionnement
- 1 : 10 split
- Densité de semis
- 3-5*10^5/ml
- Renouvellement des fluides
- Subculture : 2 times/week
- Décongélation et mise en culture
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.
Follow the procedure described under Post-Thaw Recovery
07Contrôle qualité et cryoconservation
- Milieu de congélation
- As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
- Conditions de stockage
For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.
- Conditions de livraison
Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
08Donateur
- Âge du donneur
- 14 years
- Origine ethnique
- Japanese
09Aspects juridiques et sécurité
- Consignes de sécurité
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
- Garantie
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Un accord de transfert de matériel est requis
- Oui
10Détails du produit
- Tableau de composition